Correlative serum biomarker analyses: Lenvatinib (LEN) plus pembrolizumab (PEMBRO) in a phase Ib/II trial in advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Lee, C. H.; Adachi, Y.; Ikezawa, H.; Li, S. D.; Funahashi, Y.; Minoshima, Y.; Kubiak, P.; Perini, R.; Ren, M.; Smith, A. D.; Motzer, R. J. |
| Abstract Title: | Correlative serum biomarker analyses: Lenvatinib (LEN) plus pembrolizumab (PEMBRO) in a phase Ib/II trial in advanced renal cell carcinoma (RCC) |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S564 |
| End Page: | S565 |
| Language: | English |
| ACCESSION: | WOS:000573469101007 |
| DOI: | 10.1016/j.annonc.2020.08.791 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 719P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
